financetom
Business
financetom
/
Business
/
J&J acquires rights to skin disorder drug for $1.25 bln
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
J&J acquires rights to skin disorder drug for $1.25 bln
May 28, 2024 5:05 AM

May 28 (Reuters) - Johnson & Johnson ( JNJ ) said on

Tuesday that it had agreed to acquire the rights to an

experimental skin disorder treatment from privately held Numab

Therapeutics for about $1.25 billion.

J&J will acquire Numab's unit for the global rights to the

drug, called NM26.

(Reporting by Christy Santhosh in Bengaluru; Editing by Anil

D'Silva)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved